HOME >> BIOLOGY >> NEWS
New slant on vision research: Neurons sensitive to viewing angle

another image of the same face or object--called the test image--was flashed on the screen. But this time, the image was either head-on or turned very slightly (three or six degrees) to one side or the other. Whatever the orientation of the test image, subjects were required to choose whether it was turned to the right or the left.

When subjects were presented with an adapting image turned 30 degrees to one side, then tested with an image of the same thing in head-on view, they tended to say the test image was tilted in the opposite direction of the adapting image. That is, if they first saw the face of a man turned 30 degrees to the left, then saw his face head-on, they said the face was turned to the right. This "adaptation effect" occurred 80 percent of the time; normally, responses for both directions would be equally likely. Even if the test image was turned three degrees in the same direction as the adapting image, the subjects guessed wrong half the time, saying the test image was turned in the other direction.

The reason for the errors is that when a person stares at an image, neurons that respond to the viewing angle of the image get "tired" and become less responsive when a very similar image is presented again, He said. The brain interprets this lack of response as the object not being turned in the direction the neurons are attuned to. This suggests that there are separate populations of neurons, each responding to a particular narrow range of orientations. The neurons are likely located in the lateral occipital cortex, an area of the cerebral cortex very far back on either side of the head.

The researchers also performed experiments that suggested that for faces, at least, subjects were not deciding the orientation of test images based on "local" features such as noses. When subjects saw unorganized fragments of faces--as if parts of the face were simply erased--as adapting images, no adaptation effect occurred.

"This
'"/>


2-Mar-2005


Page: 1 2 3

Related biology news :

1. A unique arrangement for egg cell division
2. Research shows NPD1 protects a key component of vision
3. Researchers find pathway that controls cell size and division
4. Major breakthrough in understanding how HIV interferes with infected cell division
5. Color vision drove primates to develop red skin and hair, study finds
6. UF researchers awaken vision cells in blind mice
7. Berkeley Lab Life Sciences division awarded NIH grants for fruit fly, nematode studies
8. Stem cell therapy shows promise for rescuing deteriorating vision
9. Genetic studies endow mice with new color vision
10. Making mice with enhanced color vision
11. Researchers at IRB Barcelona discover a new mechanism that regulates stem cell division

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New slant vision research Neurons sensitive viewing angle

(Date:4/17/2014)... hundred births, Down syndrome - or trisomy 21 - ... It results from a chromosomal abnormality where cells of ... (1% of the human genome). A study conducted by ... Genetic Medicine and Development at the University of Geneva ... shed light on how the extra chromosome 21 upsets ...
(Date:4/17/2014)... Rajendra Singh Thursday as a "Champion of Change" ... deployment in the residential, commercial and industrial sectors. ... Electrical and Computer Engineering and director of Clemson,s ... hero leading the charge across the country to ... and driving policy changes at the local level ...
(Date:4/17/2014)... channels are implicated in many serious conditions such as ... potential target for drug therapies. Unfortunately, there is still ... Cambridge research provides fresh and unexpected insight into the ... components - β-subunit molecules - which are responsible for ... published in the most recent edition of the ...
Breaking Biology News(10 mins):Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3White House honors Clemson professor as 'Champion of Change' for solar deployment 2Structure of sodium channels different than previously believed 2
(Date:1/15/2014)... Toronto, Canada (PRWEB) January 15, 2014 ... perspectives on nonclinical and clinical safety assessment in biosimilars. ... a path for biosimilar drug development, however the complex ... regards to quality, safety and efficacy extremely challenging. Based ...
(Date:1/15/2014)... 2014 Two champions of science, technology, ... of an annual competition for middle and high school ... innovative STEM study. The competition presents students with real-world ... Engineering Aptitude, Mathematics, and Sciences is a program ...
(Date:1/15/2014)... 2013 was a banner year of continued ... saw continued independent research led by the team at ... $1 million grant from the Susanne Marcus Collins Foundation, ... peer reviewed journal, Amy Grant highlighted Brainwave Optimization® in ...
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they ... Russian pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ... , Turkey and other members ... antibiotic for the treatment of bacterial infections including those ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
Cached News: